Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Akash Patil

4PUBLICATIONS
7CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

Sort by Publication Date:
|Sep 02, 2025
Oncolytic peptide NF27 effectively inhibits tumor growth and eradicates tumors in multiple cancer types.

Natsuki Furukawa, Alex R Chao, Wendy Yang

|Apr 02, 2024
Chemokine-derived oncolytic peptide induces immunogenic cancer cell death and significantly suppresses tumor growth.

Natsuki Furukawa, Wendy Yang, Alex R Chao

|Oct 27, 2023
Chemokine-derived oncolytic peptide induces immunogenic cancer cell death and significantly suppresses tumor growth.

Natsuki Furukawa, Wendy Yang, Alex Chao

|Sep 14, 2020
Regulation of the tumor immune microenvironment and vascular normalization in TNBC murine models by a novel peptide.

Adam C Mirando, Akash Patil, Christine I Rafie

Pageof 1

Frequent Collaborators

3 joint publications

Adam C Mirando

3 joint publications

Natsuki Furukawa

2 joint publications

Niranjan B Pandey

2 joint publications

Aleksander S Popel

1 joint publications

Elizabeth M Jaffee

1 joint publications

Evanthia T Roussos Torres

1 joint publications

Eric S Christenson

Frequent Collaborators

3 joint publications

Adam C Mirando

3 joint publications

Natsuki Furukawa

2 joint publications

Niranjan B Pandey

2 joint publications

Aleksander S Popel

Top Related Videos

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on : Jan 07, 2019

9.6K
<em>In Vivo</em> Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells
08:02

<em>In Vivo</em> Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells

Published on : Sep 23, 2021

2.6K
See more related videos

Top Related Videos

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on : Jan 07, 2019

9.6K
<em>In Vivo</em> Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells
08:02

<em>In Vivo</em> Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells

Published on : Sep 23, 2021

2.6K
See more related videos